Hinova Pharmaceuticals Inc. (SHA:688302)

China · Delayed Price · Currency is CNY

33.15

+0.75 (2.31%)

At close: Aug 4, 2026

Hinova Pharmaceuticals Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	46.5	20.47	0.37	-	1.65	-
Revenue Growth	12574.70%	5480.11%	-	-	-	-
Gross Profit	46.17	20.19	0.03	-	0.88	-
Operating Income	-166.38	-173.51	-227.91	-336.69	-347.87	-345.27
Net Income	-135.03	-137.25	-199.5	-294.16	-301.51	-306.18
Earnings Per Share	-1.37	-1.39	-2.01	-2.97	-3.32	-4.12
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	20.47
Overseas	0
Total	20.47

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	827.74	857.93	843.93	1,104	1,568	901.22
Total Debt	105.04	105.89	9.05	12.85	35.76	3.91
Net Cash (Debt)	722.71	752.04	834.88	1,091	1,532	897.31
Net Cash Growth	-6.67%	-9.92%	-23.48%	-28.79%	70.74%	-21.16%
Net Cash Per Share	7.33	7.62	8.41	11.02	16.87	12.07

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-84.75	-108.88	-187.08	-255.51	-314.92	-227.82
Capital Expenditures	-64.46	-82.89	-89.55	-99.18	-69.21	-19.77
Free Cash Flow	-149.21	-191.76	-276.63	-354.68	-384.13	-247.6
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	99.29%	98.62%	8.43%	-	53.57%	-
Operating Margin	-357.85%	-847.65%	-62127.45%	-	-21072.49%	-
Pretax Margin	-290.41%	-670.50%	-54379.48%	-	-18264.53%	-
Profit Margin	-290.42%	-670.51%	-54382.81%	-	-18264.53%	-
FCF Margin	-320.91%	-936.81%	-75410.46%	-	-23269.07%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	70.60	237.84	8289.18	-	2418.38	-